Pricing

ALX Oncology

0 followers

‌

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.

Industries

Biotechnology

Headquarters

Burlingame, United States

Employees

11-50

Links

Org chart

Jaume Pons

President & Chief Scientific Officer

Jaume Pons

Collapse

Sophia Randolph

Chief Medical Officer

Jeanne Jew

Chief Business Officer

Chris Byrd

General Counsel

Athanasios Tsiatis

SVP, Clinical Development

Yeong-Liang Lin

SVP, Drug Safety & Pharmacovigilance

Michael Chang

VP, Operations

Hank Stern

VP, Chemistry, Manufacturing & Controls

Susan Vermeir

VP, Regulatory Affairs & Quality

Hadi Falahatpisheh

VP, Preclinical Development

Marija Vrljic

VP, Antibody Technologies

Sue Naim

VP, Clinical Operations

Shelly Pinto

Interim Chief Financial Officer

Teams

Clinical Development and Operations

11 members

Leadership Team

8 members

Regulatory Affairs and Compliance

6 members

Similar companies

Longeveron

1 follower

HydroPeptide LLC

3 followers

Thermo Fisher Scientific

155 followers

Agilent Technologies

63 followers

Myriad Genetics

35 followers

bluebird bio

38 followers

Exact Sciences

15 followers

Natera

13 followers

CRISPR Therapeutics

9 followers

Amyris

8 followers

Legend Biotech

5 followers

Explore companies